Daxor expands BVA technology into three new hospitals

Daxor (DXR) announces the expansion of its blood volume analysis technology into three new hospitals, a testament to the growing recognition of BVA’s essential role in improving lives and reducing healthcare costs. This growth is driven by a combination of Daxor’s state-of-the-art CLIA-certified ezBVA Lab service, which delivers on-demand, next-day blood volume analysis results, and an on-site placement of its blood volume analyzer. The company expects accelerated sales growth to continue throughout 2025 as clinicians increasingly embrace the benefits of BVA for optimizing fluid management decisions. Recent sales wins include: Expansion into a key Tennessee medical center within a large integrated community healthcare system in the Appalachian Highlands, is adopting ezBVA Lab services for inpatient and outpatient cardiology applications; A major hospital serving Arkansas is integrating BVA with an on-site analyzer to enhance its advanced heart care programs for both inpatient and outpatient settings; A leading referral hospital serving Arizona, Nevada and Utah is utilizing Daxor’s ezBVA Lab service for its advanced heart failure patients, both inpatient and outpatient.